JERSEY CITY, N.J., Dec. 13, 2023 /PRNewswire/ — InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Next-Generation Complement Therapeutics Market Size, Share & Trends Analysis Report By Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Paroxysmal Nocturnal Hemoglobinuria, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre… Continue reading Next Generation Complement Therapeutics Market worth $23.04 Bn by 2031 – Exclusive Report by InsightAce Analytic
Category: Newswire
Größtes Branchentreffen auf der COP28 legt Pläne für eine Netto-Null-Zukunft fest
DUBAI, VAE, 13. Dezember 2023 /PRNewswire/ — Nach einem Tag aktiver Diskussionen auf der Initiative Shaping the Future of Shipping: Delivering a Net Zero World am 10. Dezember wurden die Weichen für die Umsetzung der Netto-Null-Strategie der Internationalen Seeschifffahrtsorganisation (IMO) gestellt. Die Brancheninitiative brachte mehr als 60 Organisationen zusammen, um konkrete Lösungen zu erörtern, mit denen… Continue reading Größtes Branchentreffen auf der COP28 legt Pläne für eine Netto-Null-Zukunft fest
Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval
STOCKHOLM, Dec. 13, 2023 /PRNewswire/ — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that it has signed an agreement with Lonza for the manufacture of a new GMP campaign of fostrox drug substance for the planned phase 2b… Continue reading Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval
Roofing Market to hit USD 342.8 Billion by 2033, Says We Market Research
CHICAGO, Dec. 13, 2023 /PRNewswire/ — As per the most recent analysis conducted by We Market Research, the Roofing Market is on track to reach a value of $342.8 Billion by the end of 2033. Looking ahead, the market’s prospects appear even more impressive, with projections suggesting a significant increase to $197.6 Billion in 2023.… Continue reading Roofing Market to hit USD 342.8 Billion by 2033, Says We Market Research
United States Butyric Acid Industry Report 2023: Market to Reach $291.5 Million by 2028 – Transforming the Flavor Profile of Food and Beverages
DUBLIN, Dec. 13, 2023 /PRNewswire/ — The “United States Butyric Acid Market Competition Forecast & Opportunities, 2028” report has been added to ResearchAndMarkets.com’s offering. United States Butyric Acid Market, valued at USD 185.23 million in 2022, is poised for robust growth throughout the forecast period, projected to exhibit a Compound Annual Growth Rate (CAGR) of 8.11%… Continue reading United States Butyric Acid Industry Report 2023: Market to Reach $291.5 Million by 2028 – Transforming the Flavor Profile of Food and Beverages
Dizal’s Sunvozertinib Pivotal Study Results Published in The Lancet Respiratory Medicine
SHANGHAI, Dec. 13, 2023 /PRNewswire/ — Dizal today announced that the results of a phase 2 pivotal study of sunvozertinib for the treatment of platinum-pretreated non-small-cell lung cancer (NSCLC) patients with EGFR exon 20 insertion mutations (exon20ins) (WU-KONG6) were published in the peer-reviewed journal The Lancet Respiratory Medicine (IF: 76.2). The publication of these research… Continue reading Dizal’s Sunvozertinib Pivotal Study Results Published in The Lancet Respiratory Medicine
GENAI Appoints Tech Entrepreneur Patrick Gray as COO and Announces Changes to the Board
VANCOUVER, BC, Dec. 13, 2023 /PRNewswire/ – Generative AI Solutions Corp. (“GenAI” or the “Company”) (CSE: AICO) (OTC: AICOF) is pleased to announce that Patrick Gray, a former director of the Company, has been appointed Chief Operating Officer (“COO“) of the Company. In connection with his appointment as COO, Mr. Gray is resigning from the Board of Directors… Continue reading GENAI Appoints Tech Entrepreneur Patrick Gray as COO and Announces Changes to the Board
Acesion Pharma announces Nature Medicine publication of clinical results in Atrial Fibrillation
AP30663 achieved proof of mechanism with first-in-class SK channel inhibition compound in atrial fibrillation – primary endpoint met: 99.9% probability of superiority over placebo AP31969, a novel compound being developed for sinus rhythm maintenance in atrial fibrillation, commences dosing in phase 1 COPENHAGEN, Denmark, Dec. 13, 2023 /PRNewswire/ — Acesion Pharma (“Acesion” or “the Company”), a… Continue reading Acesion Pharma announces Nature Medicine publication of clinical results in Atrial Fibrillation
Bybit’s Spot X: The Aggregator Transforming Crypto Spot Trading
DUBAI, UAE, Dec. 13, 2023 /PRNewswire/ — Bybit, the third largest crypto exchange by volume, is excited to announce the launch of Spot X, an innovative spot trading aggregator designed to enhance and reward the trading experience of its 20 million users worldwide. Continue Reading Bybit’s Spot X: The Aggregator Transforming Crypto Spot Trading Spot… Continue reading Bybit’s Spot X: The Aggregator Transforming Crypto Spot Trading
Multiagency Investment In AI-Driven Data Harmonization
ARLINGTON, Va. and ANNAPOLIS, Md., Dec. 13, 2023 /PRNewswire/ — In a joint effort spanning the Department of Defense and the Department of Health and Human Services, the Defense Advanced Research Projects Agency (DARPA) and the Advanced Research Projects Agency for Health (ARPA-H) have selected Netrias to increase its technological scope and applicability of PathEngine, a… Continue reading Multiagency Investment In AI-Driven Data Harmonization